Gabapentin Market revenue is expected to increase by USD 4.1 Billion by 2032, with a 5.7% CAGR from 2023 to 2032 LOS ANGELES, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The Gabapentin Market Size accounted for USD 2.4 Billion in 2022 and is projected to achieve a market size of USD 4.1 Billion by 2032 growing at a CAGR...

Gabapentin Market Size to Hit USD 3.7 Billion by 2032 at 5.90% CAGR – Report by Market Research Future (MRFR) New York, USA, July 11, 2023 (GLOBE NEWSWIRE) -- Gabapentin Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Gabapentin Market Information By...

Global Gabapentin Market is Expected to Reach US$ 3.54 Billion at a CAGR of 5.3% During Forecast Period of 2023 to 2033 | Recent Report by Future Market Insights, Inc. NEWARK, Del, April 04, 2023 (GLOBE NEWSWIRE) -- The gabapentin market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is...

Global Gabapentin Market [2022-2027] | COVID-19 Impact with Top Manufacturers Analysis (Novartis, TEVA, Mylan, Pfizer, etc) | Industry Size-Share, Demand-Supply Scenario, Emerging Trends, Production, Opportunities and Challenges Pune, March 24, 2022 (GLOBE NEWSWIRE) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Gabapentin Market” Research Report 2022-2027 is a historical...